Anticorps polyclonal anti-TCP2L de lapin (ELK Biotechnology)
Know who made it. See the evidence. Buy through one marketplace.
L'anticorps polyclonal de lapin TCP2L est un anticorps d'ELK Biotechnology pour les flux de travail de recherche impliquant TCP2L.
| Spécificité | Cet anticorps détecte les niveaux endogènes de TCP2L chez l'homme |
|---|---|
| Légendes des preuves de validation | Analyse par Western blot des lysats de cellules 3T3, l'anticorps primaire a été dilué à 1:1000, 4° pendant la nuit |
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Espèce | WB | IHC | IF | ELISA | IP | FCM | ChIP |
|---|---|---|---|---|---|---|---|
| Humain | |||||||
| Rat | |||||||
| Souris |
This product is manufactured by ELK Biotechnology and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
